Minretumomab Biosimilar, Human TAG-72 mAb
Item Information
Catalog #
Size
Price
Description
Minretumomab is a humanized IgG1-kappa monoclonal antibody designed to attack cancers expressing TAG-72, including breast, colon, lung, and pancreatic cancers. This Minretumomab biosimilar has the same amino acid sequence as humanized Minretumomab.
Product Overview
Isotype
IgG1 kappa
Source
Produced in a mammalian stable cell line.
Formulation
0.2-uM filtered solution, pH 7.4, no stabilizers or preservatives
Purity
>95% by SDS-PAGE under reducing conditions and HPLC
Endotoxin
<1 EU/mg (LAL method)
Specificity/Sensitivity
Binds to human TAG-72.
Storage
4°C if used within 1 month, -20°C otherwise
Shipping Information
Shipped with an ice pack.
Application
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and assays for studying the biological pathways affected by Minretumomab.
For Research Use Only. Not for use in diagnostic procedures.